Private Equity Firm Healthcare

Riverside Partners

Boston, MA, United States

Founded in 1989, Riverside Partners is a Boston-based middle market private equity firm currently investing Riverside Fund VI, L.P. The firm focuses on growth-oriented companies primarily in healthcare and technology and typically invests in North American companies with $3–15M of EBITDA.

Focus Areas
Private equity investing (healthcare, technology

Tracked deals

14

14 tracked deals across 2016-2026.

Recent pace

2

2 tracked deals announced in the last 12 months.

Deal mix

Addon

6 addon · 5 buyout · 2 growth capital

Riverside Partners Acquisition Volume by Year

Last 5 years

Acquisition volume by year Annual acquisition counts for the last 5 years for Riverside Partners. 1 2019 7 2022 1 2023 2 2024 ~3 est. 2 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

Showing the 12 most recent of 14 tracked deals for Riverside Partners.

  • RS2 Healthcare Partners Invests in KMM Group
    July 27, 2026
    Buyer
    RS2 Healthcare Partners
    Target
    KMM Group
    Industry
    Healthcare Services
    Location
    United States
    Type
    Growth capital

    KMM Group, a vertically integrated precision contract manufacturer for the medical device industry, announced the completion of an investment by RS2 Healthcare Partners. In connection with the investment, KMM appointed industry veteran J. Mark King as President and Chief Executive Officer, with co-founders John Shegda (Chief Technology Officer) and Eric Wilhelm (Executive VP, Business Transformation & Organizational Capability) taking key leadership roles.

  • RS2 Healthcare Partners (Riverside Partners) Completes Loftware Continuation Vehicle Led by AKKR Strategic Capital
    May 11, 2026
    Buyer
    RS2 Healthcare Partners, AKKR Strategic Capital (Accel-KKR)
    Target
    Loftware, Inc.
    Industry
    Cloud & SaaS
    Location
    United States
    Type
    Recapitalization

    RS2 Healthcare Partners (formerly Riverside Partners) completed a single-asset continuation vehicle for Loftware, a global enterprise labeling and artwork management software provider. Accel-KKR’s AKKR Strategic Capital served as lead investor, providing additional committed capital to support Loftware’s future growth and enabling RS2 to pursue new platform investments.

  • Riverside Partners Combines Sequoia Biotech Consulting and Syner-G BioPharma Group
    September 18, 2024
    Buyer
    Riverside Partners, LLC
    Target
    Sequoia Biotech Consulting, Syner-G BioPharma Group
    Industry
    Healthcare Services
    Location
    United States
    Type
    Addon

    Boston-based private equity firm Riverside Partners has combined two of its portfolio companies, Sequoia Biotech Consulting and Syner-G BioPharma Group, into a single, integrated life‑sciences services business. The combined organization — bringing together regulatory, development, quality, and operational capabilities — has approximately 500 employees and will provide end-to-end solutions to pharmaceutical, biotechnology, and medical device clients.

  • Riverside Partners Invests in Net32
    May 7, 2024
    Buyer
    Riverside Partners
    Target
    Net32, Inc.
    Industry
    Dental
    Location
    North Carolina, United States
    Type
    Growth capital

    Boston-based private equity firm Riverside Partners completed a growth investment in Net32, a Cary, North Carolina-based online marketplace for dental supplies. The partnership will provide capital and resources to support Net32's product innovation, vendor growth, and continued expansion of its marketplace for dental practices.

  • Syner-G BioPharma Group (Riverside Partners) Acquires RMC Pharmaceutical Solutions
    January 24, 2023
    Buyer
    Syner-G BioPharma Group, Riverside Partners
    Target
    RMC Pharmaceutical Solutions
    Industry
    Healthcare Services
    Location
    Colorado, United States
    Type
    Addon

    Syner-G BioPharma Group, a portfolio company of Riverside Partners, has acquired RMC Pharmaceutical Solutions, an outsourced CMC and quality management services provider based in Colorado. The add-on strengthens Syner-G's pharmaceutical science capabilities—particularly biologics and cell & gene therapy development—by integrating RMC's process and analytical development, regulatory strategy, and quality management expertise.

  • Convergence Networks Acquires SWAT Systems
    August 16, 2022
    Buyer
    Convergence Networks, Riverside Partners
    Target
    SWAT Systems
    Industry
    IT Services
    Location
    Washington, United States
    Type
    Addon

    Convergence Networks, a Riverside Partners-backed managed IT and cybersecurity platform, has acquired Seattle-based SWAT Systems, a provider of managed IT, cybersecurity, and communication services. The add-on expands Convergence Networks' technical bench and Seattle-area footprint; financial terms were not disclosed.

  • Calero-MDSL Acquires Network Control
    August 2, 2022
    Buyer
    Calero-MDSL, Riverside Partners, Oak Hill Capital Partners
    Target
    Network Management and Control Corporation (Network Control)
    Seller
    Network Management and Control Corporation, Mark Hearn (owner and CEO)
    Industry
    Software
    Location
    Iowa, United States
    Type
    Addon

    Calero-MDSL, a portfolio company of Riverside Partners and Oak Hill Capital, has acquired Network Control, a boutique Telecom Expense Management (TEM) and managed mobility provider headquartered in Waverly, Iowa. The deal brings Network Control's high-touch TEM team and operations into Calero-MDSL to accelerate growth in the mid-market; Mark Hearn, Network Control's owner and CEO, will join Calero-MDSL as Vice President and General Manager of the Network Control business unit.

  • Riverside Partners Completes Platform Investment in UnisLink
    May 10, 2022
    Buyer
    Riverside Partners
    Target
    UnisLink Holdings LLC
    Industry
    Healthcare Services
    Location
    Arizona, United States
    Type
    Buyout

    Riverside Partners, a Boston-based private equity firm, completed a new platform investment in UnisLink Holdings LLC, a Phoenix-headquartered provider of end-to-end revenue cycle management and population health management services. The founders will remain in management and retain a large equity stake; Riverside said it will support UnisLink's next stage of growth both organically and through acquisitions. Financial terms were not disclosed.

  • GrowthCurve Capital Completes Acquisition of Revecore
    April 5, 2022
    Buyer
    GrowthCurve Capital, Riverside Partners, Revecore management
    Target
    Revecore
    Seller
    Riverside Partners
    Industry
    Healthcare Services
    Location
    Tennessee, United States
    Type
    Buyout

    GrowthCurve Capital has completed an acquisition of Revecore, a provider of revenue integrity and complex claims solutions for hospitals and health systems. Riverside Partners and Revecore management will remain significant shareholders while GrowthCurve will invest to accelerate the company's technology, AI and data capabilities and support continued growth.

  • Syner-G Acquires Impact Pharmaceutical Services
    February 1, 2022
    Buyer
    Syner-G BioPharma Group, Riverside Partners
    Target
    Impact Pharmaceutical Services
    Industry
    Healthcare Services
    Location
    North Carolina, United States
    Type
    Addon

    Syner-G BioPharma Group, a portfolio company of Riverside Partners, has acquired Impact Pharmaceutical Services, a Research Triangle Park-based provider of medical writing, regulatory strategy, and regulatory publishing services for biotech and pharmaceutical clients. The deal, which closed in late December, expands Syner-G's CMC and regulatory capabilities to better support clients across pre-IND through post-marketing stages; financial terms were not disclosed.

  • Riverside Partners Completes Platform Investment in Sequoia Consulting Group
    January 18, 2022
    Buyer
    Riverside Partners, LLC
    Target
    Sequoia Consulting Group, LLC
    Industry
    Healthcare Services
    Location
    California, United States
    Type
    Buyout

    Riverside Partners, a Boston-based private equity firm, completed a platform investment in Sequoia Consulting Group, a San Diego–headquartered life sciences consulting firm led by founder and CEO Brandy Bullen. The partnership will support Sequoia’s growth, capability expansion, and geographic reach as the company continues to provide technical operations, quality and scientific operations, business transformation, and program/project management services to biotech, pharma, diagnostics, and medical device clients.

  • Loftware (Riverside-backed) Acquires PRISYM ID
    January 11, 2022
    Buyer
    Loftware, Inc., Riverside Partners
    Target
    PRISYM ID
    Industry
    Cloud & SaaS
    Location
    England, United Kingdom
    Type
    Addon

    Loftware, a Riverside Partners portfolio company, has acquired PRISYM ID to expand its cloud-based enterprise labeling platform with regulated content and clinical trial labeling capabilities. The deal strengthens Loftware's offering for medical device, pharmaceutical and clinical trial customers and broadens its position in life-sciences labeling and regulated content management.

Related Acquisition Pages

Healthcare Services Buyers & Acquisitions 8 tracked deals by Riverside Partners. Cloud & SaaS Buyers & Acquisitions 3 tracked deals by Riverside Partners. Dental Buyers & Acquisitions 1 tracked deal by Riverside Partners. IT Services Buyers & Acquisitions 1 tracked deal by Riverside Partners. Acquisitions in North Carolina 2 tracked deals by Riverside Partners. Acquisitions in Arizona 1 tracked deal by Riverside Partners. Acquisitions in California 1 tracked deal by Riverside Partners. Acquisitions in Colorado 1 tracked deal by Riverside Partners.

Selling a company? Get in front of buyers like Riverside Partners

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →